HQL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HQL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
abrdn Life Sciences Investors's dividends per share for the six months ended in Sep. 2023 was $0.64. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.28. Its Dividend Payout Ratio for the six months ended in Sep. 2023 was 0.00. As of today, abrdn Life Sciences Investors's Dividend Yield % is 9.79%.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of abrdn Life Sciences Investors is 1.62, which seems too high.
Warning Sign:
abrdn Life Sciences Investors stock dividend yield is close to 2-year low.
During the past 12 months, abrdn Life Sciences Investors's average Dividends Per Share Growth Rate was -12.90% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -4.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of abrdn Life Sciences Investors was 0.80% per year. The lowest was -4.50% per year. And the median was -1.50% per year.
For more information regarding to dividend, please check our Dividend Page.
The historical data trend for abrdn Life Sciences Investors's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Life Sciences Investors Annual Data | ||||||||||||||||
Trend | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||
Dividends per Share | Get a 7-Day Free Trial | 1.49 | 1.47 | 1.67 | 1.47 | 1.28 |
abrdn Life Sciences Investors Semi-Annual Data | |||||||||||||
Sep17 | Mar18 | Sep18 | Mar19 | Sep19 | Mar20 | Sep20 | Mar21 | Sep21 | Mar22 | Sep22 | Mar23 | Sep23 | |
Dividends per Share | Get a 7-Day Free Trial | 0.84 | 0.81 | 0.66 | 0.64 | 0.64 |
For the Asset Management subindustry, abrdn Life Sciences Investors's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where abrdn Life Sciences Investors's Dividend Yield % falls into.
Dividends paid to per common share.
abrdn Life Sciences Investors (NYSE:HQL) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
abrdn Life Sciences Investors's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Sep. 2023 ) | / | EPS without NRI (Q: Sep. 2023 ) |
= | 0.64 | / | -0.48 | |
= | N/A |
During the past 7 years, the highest Dividend Payout Ratio of abrdn Life Sciences Investors was 1.62. The lowest was 0.29. And the median was 0.63.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of abrdn Life Sciences Investors is 1.62, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
abrdn Life Sciences Investors Recent Full-Year* Dividend History
Amount | Ex-date | Record Date | Pay Date | Type | Frequency | Forex Rate |
---|---|---|---|---|---|---|
USD 0.390000 | 2024-02-21 | 2024-02-22 | 2024-03-28 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.300000 | 2023-11-21 | 2023-11-22 | 2024-01-10 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.320000 | 2023-08-24 | 2023-08-25 | 2023-09-29 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.320000 | 2023-05-24 | 2023-05-25 | 2023-06-30 | Cash Dividend | quarterly | USD:USD 1.000000 |
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
abrdn Life Sciences Investors's Dividend Yield (%) for Today is calculated as
Dividend Yield % | = | Most Recent Full Year Dividend | / | Current Share Price |
= | 1.33 | / | 13.59 | |
= | 9.79 % |
Current Share Price is $13.59.
abrdn Life Sciences Investors's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.33.
During the past 7 years, the highest Dividend Yield of abrdn Life Sciences Investors was 12.38%. The lowest was 6.65%. And the median was 9.20%.
Warning Sign:
abrdn Life Sciences Investors stock dividend yield is close to 2-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of abrdn Life Sciences Investors's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd Reit | director | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Bill Maher | director | 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101 |
Rose Dimartino | director | C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103 |
James Joseph O'connor | other: Director of Adviser | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Marika Tooze | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Aberdeen Standard Investments Inc. | other: Adviser | 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103 |
Jaclyn Marie Matsick | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Lucia Sitar | officer: VP and Chief Legal Officer | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Jennifer A Nichols | other: Director of Adviser | 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Christian Pittard | officer: President | ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH |
Megan Kennedy | officer: Secretary and Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Sharon Ferrari | officer: Treasurer and CFO | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Alan R Goodson | officer: Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Joseph Andolina | officer: Chief Compliance Officer & VP | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Stephen Bird | director | 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022 |
From GuruFocus
By Business Wire Business Wire • 08-16-2022
By Business Wire Business Wire • 05-18-2020
By Business Wire Business Wire • 03-31-2023
By Business Wire Business Wire • 12-31-2020
By Business Wire Business Wire • 05-15-2023
By Business Wire Business Wire • 12-31-2021
By Business Wire Business Wire • 05-18-2021
By Business Wire Business Wire • 03-31-2022
By Business Wire Business Wire • 03-22-2022
By Business Wire Business Wire • 11-12-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.